Development of rapid advice guideline and standard and continuous updating guideline: experiences and practice

Area of Science:

• Infectious Diseases
• Public Health Policy
• Clinical Practice Guidelines

Background:

• Two distinct guidelines for coronavirus disease 2019 (COVID-19) management were published on February 6, 2020, and September 4, 2020.
• These guidelines differed significantly in their development, evidence base, and recommendation strength.

Purpose of the Study:

• To share experiences from the development of two COVID-19 management guidelines.
• To enhance clinical practitioners' understanding and implementation of guidelines.
• To facilitate communication and discussion among guideline developers during the pandemic.

Main Methods:

• Comparative analysis of guideline development processes.
• Review of evidence grading and recommendation frameworks.
• Documentation of challenges and facilitators in guideline creation.

Main Results:

• Significant variations identified in the background, evidence, and recommendations between the two guidelines.
• Experience sharing focused on practical aspects of guideline development and implementation.
• Identified needs for improved communication strategies in guideline development.

Conclusions:

• Understanding the differences in guideline development is crucial for effective clinical application.
• Sharing development experiences can improve future guideline creation and implementation.
• Pandemic conditions necessitate adaptive and transparent guideline development processes.